financetom
Business
financetom
/
Business
/
Cintas' UniFirst Acquisition Accretive to Company's EPS by 10% by Year-Four, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas' UniFirst Acquisition Accretive to Company's EPS by 10% by Year-Four, UBS Says
Mar 12, 2026 8:41 AM

11:22 AM EDT, 03/12/2026 (MT Newswires) -- Cintas' ( CTAS ) deal to acquire UniFirst ( UNF ) is estimated to be accretive to Cintas' ( CTAS ) earnings per share, versus the standalone company, by about 10% by year-four, considering the expected customer churn, cost synergies, and debt paydown, UBS said in a Wednesday note.

With Cintas ( CTAS ) expecting to more than double UniFirst's ( UNF ) earnings before interest, taxes, depreciation and amortization by the end of the four-year integration, UBS said that this "numerically" provides Cintas ( CTAS ) pathway to 10% or more EBITDA compound annual growth rate over the next four years.

UBS further said that at a high-level, the acquisition will increase Cintas' ( CTAS ) revenue by about 20%.

UBS maintained its buy rating on Cintas ( CTAS ) with a $235 price target.

Price: 198.13, Change: -0.21, Percent Change: -0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mullen Automotive Delivers First Batch of EVs in $210 Million Deal With Volt Mobility
Mullen Automotive Delivers First Batch of EVs in $210 Million Deal With Volt Mobility
Sep 5, 2024
11:15 AM EDT, 09/04/2024 (MT Newswires) -- Mullen Automotive ( MULN ) said Wednesday it has shipped the initial batch of electric vehicles under a $210 million purchase contract with United Arab Emirates-based Volt Mobility. The company expects to book revenue from the deal in its fiscal Q1 that begins Oct. 1. Volt has ordered 3,000 Mullen Class 1 and...
UK regulator finds no suicidal thoughts link to diabetes, obesity drugs
UK regulator finds no suicidal thoughts link to diabetes, obesity drugs
Sep 5, 2024
LONDON, Sept 4 (Reuters) - Britain's health regulator said on Wednesday that the available data does not establish a link between a popular class of diabetes and obesity drugs, including Novo Nordisk's Wegovy, and suicidal thoughts. The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists,...
Google limits on access to Android Auto may breach EU rules, court adviser says
Google limits on access to Android Auto may breach EU rules, court adviser says
Sep 5, 2024
BRUSSELS, Sept 5 (Reuters) - An adviser to Europe's top court on Thursday sided with Italy's antitrust authority, saying Alphabet unit Google's refusal to allow an e-mobility app developed by Enel access to its Android Auto platform may breach competition rules. Google's refusal to provide third-party access to Android Auto platform may be in breach of competition rules, Advocate General...
Royalty Pharma, Ascendis Pharma Unit Have $150 Million Royalty Funding Agreement
Royalty Pharma, Ascendis Pharma Unit Have $150 Million Royalty Funding Agreement
Sep 5, 2024
05:49 PM EDT, 09/03/2024 (MT Newswires) -- Royalty Pharma plc ( RPRX ) entered into a $150 million capped synthetic royalty funding agreement with an Ascendis Pharma ( ASND ) unit. The Ascendis Pharma Bone Diseases subsidiary will get an upfront payment of $150 million in exchange for a 3% royalty on US net sales of Yorvipath, a hormone replacement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved